| Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm … RL Coleman, D Lorusso, C Gennigens, A González-Martín, L Randall, ... The Lancet Oncology 22 (5), 609-619, 2021 | 232 | 2021 |
| Low-grade serous ovarian cancer: state of the science B Slomovitz, C Gourley, MS Carey, A Malpica, IM Shih, D Huntsman, ... Gynecologic oncology 156 (3), 715-725, 2020 | 97 | 2020 |
| Diagnostic performance of risk of ovarian malignancy algorithm against CA125 and HE4 in connection with ovarian cancer: a meta-analysis F Dayyani, S Uhlig, B Colson, K Simon, V Rolny, D Morgenstern, ... International Journal of Gynecologic Cancer 26 (9), 2016 | 86 | 2016 |
| Rate of vaginal cuff separation following laparoscopic or robotic hysterectomy AM Nick, J Lange, M Frumovitz, PT Soliman, KM Schmeler, ... Gynecologic oncology 120 (1), 47-51, 2011 | 82 | 2011 |
| Molecular clustering based on ERα and EIG121 predicts survival in high-grade serous carcinoma of the ovary/peritoneum MP Schlumbrecht, SS Xie, GL Shipley, DL Urbauer, RR Broaddus Modern Pathology 24 (3), 453-462, 2011 | 79 | 2011 |
| S100A4 mediates endometrial cancer invasion and is a target of TGF-β1 signaling R Xie, MP Schlumbrecht, GL Shipley, S Xie, RL Bassett Jr, RR Broaddus Laboratory investigation 89 (8), 937-947, 2009 | 76 | 2009 |
| A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced gynecologic and breast malignancies JW Moroney, MP Schlumbrecht, T Helgason, RL Coleman, S Moulder, ... Clinical cancer research 17 (21), 6840-6846, 2011 | 60 | 2011 |
| Clinicodemographic factors influencing outcomes in patients with low‐grade serous ovarian carcinoma MP Schlumbrecht, CC Sun, KN Wong, RR Broaddus, DM Gershenson, ... Cancer 117 (16), 3741-3749, 2011 | 48 | 2011 |
| Pericytoma With t (7; 12) and ACTB-GLI1 Fusion: Reevaluation of an Unusual Entity and its Relationship to the Spectrum of: GLI1: Fusion–related Neoplasms DA Kerr, A Pinto, TK Subhawong, BA Wilky, MP Schlumbrecht, ... The American journal of surgical pathology 43 (12), 1682-1692, 2019 | 46 | 2019 |
| Web‐based LGBT cultural competency training intervention for oncologists: Pilot study results J Seay, A Hicks, MJ Markham, M Schlumbrecht, M Bowman‐Curci, ... Cancer 126 (1), 112-120, 2020 | 41 | 2020 |
| Residential segregation and overall survival of women with epithelial ovarian cancer AC Westrick, ZD Bailey, M Schlumbrecht, WWM Hlaing, EE Kobetz, ... Cancer 126 (16), 3698-3707, 2020 | 28 | 2020 |
| Developing a web-based LGBT cultural competency training for oncologists: the COLORS training J Seay, A Hicks, MJ Markham, M Schlumbrecht, M Bowman, J Woodard, ... Patient education and counseling 102 (5), 984-989, 2019 | 28 | 2019 |
| Identifying disparities in germline and somatic testing for ovarian cancer M Huang, P Kamath, M Schlumbrecht, F Miao, D Driscoll, S Oldak, ... Gynecologic oncology 153 (2), 297-303, 2019 | 27 | 2019 |
| Gene sequencing for pathogenic variants among adults with breast and ovarian cancer in the caribbean SHL George, T Donenberg, C Alexis, V DeGennaro, H Dyer, S Yin, J Ali, ... JAMA network open 4 (3), e210307-e210307, 2021 | 26 | 2021 |
| The role of histology on endometrial cancer survival disparities in diverse Florida AL Johnson, HN Medina, MP Schlumbrecht, I Reis, EN Kobetz, ... PLoS One 15 (7), e0236402, 2020 | 25 | 2020 |
| Survivorship care needs among LGBT cancer survivors J Seay, D Mitteldorf, A Yankie, WF Pirl, E Kobetz, M Schlumbrecht Journal of psychosocial oncology 36 (4), 393-405, 2018 | 25 | 2018 |
| Implementation and feasibility of an electronic health record–integrated patient-reported outcomes symptom and needs monitoring pilot in ambulatory oncology FJ Penedo, HN Medina, PI Moreno, V Sookdeo, A Natori, C Boland, ... JCO oncology practice 18 (7), e1100-e1113, 2022 | 22 | 2022 |
| Gynecologic cancer survivor preferences for long-term surveillance M Schlumbrecht, C Sun, M Huang, A Milbourne, D Bodurka BMC cancer 18, 1-10, 2018 | 20 | 2018 |
| Cisplatin-induced bradycardia and the importance of the QT interval MP Schlumbrecht, K Hehr Journal of Oncology Pharmacy Practice 21 (2), 157-160, 2015 | 20 | 2015 |
| Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2 D Samuel, A Diaz-Barbe, A Pinto, M Schlumbrecht, S George Cells 11 (3), 539, 2022 | 19 | 2022 |
Sophia HL GeorgeUniversity of Miami Miller School of Medicine, Sylvester Comprehensive Cancer CenterVerified email at med.miami.edu
